🇺🇸 FDA
Patent

US 9464135

Epithelial membrane protein-2 (EMP2) and proliferative vitroretinopathy (PVR)

granted A61KA61K2039/505A61K9/0048

Quick answer

US patent 9464135 (Epithelial membrane protein-2 (EMP2) and proliferative vitroretinopathy (PVR)) held by THE UNITED STATES OF AMERICA DEPARTMENT OF VETERAN AFFAIRS expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE UNITED STATES OF AMERICA DEPARTMENT OF VETERAN AFFAIRS
Grant date
Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/505, A61K9/0048, A61K9/0051, A61P